Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples